Tag: Cancer: Lung
Two New Lung Cancer Meds Show Promise in Advanced Disease
Two experimental medications target mutation that fuels treatment resistance
Gene Variation May Impact Smoking Cessation Efforts
Researcher suggests a change in screening policies
AACR: Pembrolizumab Shows Promise in Advanced Lung Cancer
Keytruda (pembrolizumab) is already approved to treat melanoma
Pulmonologist Management Beneficial in NSCLC
Improved rates of stage-specific treatment for early-, advanced-stage NSCLC with comorbid COPD
Most Cancer Patients Involve Family in Treatment Decisions
Chinese-speaking Asians, Spanish-speaking Hispanics more often share decisions with family
FDA: Opdivo Approval Expanded to Include Lung Cancer
FDA approves drug for NSCLC patients who have been treated with platinum-based chemotherapy
L858R Mutation in Circulating Free DNA Is Prognostic in NSCLC
L858R mutation in tumor tissue or cfDNA is marker of shorter overall, progression-free survival
Lung-RADS Criteria Can Reduce False-Positive Result Rate
Reduction in false-positive result rate, but reduction in sensitivity also observed
Lung Cancer Now Leads Cancer Mortality in Developed Nations
Leading cancer killer of American women for many years
Sputum Biomarkers May Help ID Malignant Lung Nodules
More than 80 percent correct in ID of cancerous nodules, but accuracy still needs improving
